Scryb Inc RYMDF

Primary Symbol: C.SCYB Alternate Symbol(s): SCYRF

Healthcare Medical Devices

Scryb Inc. is a technology company that provides its platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The Company’s technologies include Cybeats, FRR, and Pharmatrac. Cybeats is an integrated security platform designed to secure and protect high-valued connected devices. The Fionet Platform is an end-to-end, rapid testing and tracking solution for community-based or decentralized settings. Combining a fast, handheld point-of-need device connected in real time to cloud data services, the Fionet Platform handles scheduling and registration via phone app at home, on-site check-in, rapid, on-the-spot antigen testing, and anonymized data and stats for dashboards for authorized stakeholders. Pharmatrac, an AI healthcare company, provides insight into medication behavior. The Company’s platform enables customers across industries to create, enhance and power disruptive solutions.

CSE:SCYB - Post by User

Scryb Inc > NEWS!

<< Previous

Bullboard Posts

Next >>

Comment by VerusSemperSorson Jun 29, 2021 9:27am

90 Views

Post# 33465314

RE:RE:RE:RE:RE:NEWS!

goldens wrote: My point was more around the statement "up to" meaing they do not have to purchase a single share. We should be back to .17 shortly. Their trial expires next week and they have provided no guidance as to a permanent contract or uptake.

I don't think that a typical NCIB includes a lower limit for the number of shares to be purchased and the 12 mllion maximum is 5% of shares outstanding - enough to make a difference I would think.

I'm more concerned about the lack of guidance. But something has had the insders buying in April, May and June.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec